| Financial Year |
March 31 2023 |
| Monetary Funds |
1,212,481,130.24 |
| Held-for-trading Financial Assets |
2,559,447.51 |
| Notes Receivable |
63,913,409.85 |
| Accounts Receivable |
555,176,823.24 |
| Advances to Suppliers |
27,697,859.71 |
| Other Receivables |
58,059,156.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
46,390,441.39 |
| Inventories |
544,145,453.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,677,327.00 |
| Total Current Assets |
2,609,477,020.90 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
590,332,028.68 |
| Investment Properties |
134,971,341.94 |
| Fixed Assetes |
468,646,475.71 |
| Under-construction Projects |
216,991,379.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
240,452,634.62 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
30,630,924.98 |
| Deferred Income Tax Assets |
36,680,047.74 |
| Other Non-Current Assets |
3,689,452.81 |
| Sub-Total of Non-Current Assets |
1,753,083,467.51 |
| Total Assets |
4,362,560,488.41 |
| Short-Term Loans |
87,998,073.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,167,710.08 |
| Accounts Payable |
342,480,362.92 |
| Accounts Received In Advance |
1,038,857.19 |
| Employee Compensation Payable |
26,473,947.62 |
| Taxes Payable |
16,229,348.98 |
| Interest Payable |
-- |
| Dividend Payable |
143,929.15 |
| Other payables |
127,266,664.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,392,169.81 |
| Other Current Liabilities |
81,509,184.12 |
| Sub-Total of Current Liabilities |
871,794,503.66 |
| Long-term Loans |
897,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
22,345,996.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,308,801.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,029,507,201.26 |
| Total Liabilities |
1,901,301,704.92 |
| Paid-In Capital(Or Share Stock) |
2,507,028,015.00 |
| Capital Surplus |
3,469,681,023.39 |
| Surplus Reserve |
260,227,370.74 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,864,642,681.53 |
| Minority Stockholder's Interest |
95,272,300.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,365,986,483.18 |
| Owner's Equity（Stockholder's Equity） |
2,461,258,783.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,362,560,488.41 |
